Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2013
03/06/2013EP2563129A1 N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
03/06/2013EP2563127A1 Prolylcarboxypeptidase inhibitors
03/06/2013EP2563126A1 Heterocyclic quinolizine derived m1 receptor positive allosteric modulators
03/06/2013EP2563125A1 Azaindoles as janus kinase inhibitors
03/06/2013EP2563123A1 Novel beta 3 adrenergic receptor agonists
03/06/2013EP2563122A1 Chemical compounds
03/06/2013EP2563120A1 Methods, compositions and kits for providing a therapeutic treatment
03/06/2013EP2563119A1 Method and medication for prevention and treatment of ocular hypertension and glaucoma
03/06/2013EP2563117A1 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
03/06/2013EP2377536B1 Methods of Using Sustained Release Aminopyridine Compositions
03/06/2013EP1792927B1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
03/06/2013EP1718283B1 Topical co-enzyme q10 formulations and methods of use
03/06/2013CN202761909U Ginger medicine hot push capsule
03/06/2013CN202761764U Cold-prevention bosom hanging buckle
03/06/2013CN1869052B Method of extracting and separating ginseng saponine mixture from ginseng leaf
03/06/2013CN1856469B Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
03/06/2013CN1826344B (1S, 5S)-3-(5, 6-dichloro-3-pyridinyl)-3, 6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
03/06/2013CN102959458A Composition for contact lens care
03/06/2013CN102958937A Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
03/06/2013CN102958936A Anellated pyridine compounds
03/06/2013CN102958935A Macrocyclic integrase inhibitors
03/06/2013CN102958934A Method for purifying fused pyrrolocarbazole derivative
03/06/2013CN102958933A Pyrazolo [1, 5 -A] pyrimidines as antiviral agents
03/06/2013CN102958932A Modulators of 5-HT receptors and methods of use thereof
03/06/2013CN102958930A 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
03/06/2013CN102958928A Dimeric SMAC Mimetics
03/06/2013CN102958927A Indazole inhibitors of kinase
03/06/2013CN102958925A Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer
03/06/2013CN102958924A Compounds and methods of treating brain disorders
03/06/2013CN102958922A 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
03/06/2013CN102958920A Metronidazole esters for treating rosacea
03/06/2013CN102958919A Novel tetrahydroquinoline derivatives
03/06/2013CN102958918A Novel nicotinamide derivatives or salts thereof
03/06/2013CN102958917A Compositions and methods for modulating the wnt signaling pathway
03/06/2013CN102958914A 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
03/06/2013CN102958911A Agomelatine hydrochloride hydrate and preparation thereof
03/06/2013CN102958908A New polymorphic form of calcimimetic compound
03/06/2013CN102958907A New polymorphic form of calcimimetic compound
03/06/2013CN102958540A Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations
03/06/2013CN102958528A Posaconazole intravenous solution formulations stabilized by substituted beta-cyclodextrin
03/06/2013CN102958527A Anti-cancer composition comprising alginate
03/06/2013CN102958526A Combination compositions of adenosine A1 agonists and non-selective beta-adrenergic receptor blockers for reducing intraocular pressure
03/06/2013CN102958525A 抗病毒化合物 Antiviral compounds
03/06/2013CN102958524A Use of 1H-quinazoline-2, 4-diones
03/06/2013CN102958523A Antitumor agent using compounds having kinase inhibitory effect in combination
03/06/2013CN102958522A Particle coating preparation
03/06/2013CN102958521A Sustained-release therapeutic agent for hypertension and renal dysfunction
03/06/2013CN102958520A Skin preparation composition for external use with excellent antibacterial and antifungal effects
03/06/2013CN102958519A Pharmaceutical compositions comprising paracetamol and process for preparing the same
03/06/2013CN102958518A Combination of a phosphoinositide 3-kinase inhibitor and an antidiabetic compound for use in the treatment of proliferative diseases
03/06/2013CN102958517A Formulations and delivery
03/06/2013CN102958516A Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning
03/06/2013CN102958515A Fexofenadine microcapsules and compositions containing them
03/06/2013CN102958513A Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration
03/06/2013CN102958509A Polymeric system for delivering preservative-free prostaglandin-based nonviscous solution
03/06/2013CN102958508A Ophthalmic devices containing chemokine antagonists
03/06/2013CN102958377A Stabilized active compound
03/06/2013CN102958366A Antimicrobial combinations of pyrion compounds with polyethyleneimines
03/06/2013CN102958362A Resveratrol-containing compositions and methods of use
03/06/2013CN102952796A Method for screening free radical quenching active substances and anti-ageing products through utilizing proteorhodopsins expressed on mitochondrial inner membranes
03/06/2013CN102952207A Preparation method and application of 6-(1-methyl-beta-carboline-3-carboxylic acetyl)-6-deoxy-beta-cyclodextrin and supramolecular inclusion complex thereof with adriamycin
03/06/2013CN102952202A Preparation method and use of ultralow-molecular weight heparin sodium
03/06/2013CN102952168A Estrogen derivative used as vasoinhibitor, as well as preparation method and medical application thereof
03/06/2013CN102952151A 3-position bis-beta-carboline alkali compound, and preparation method, pharmaceutical composition and application thereof
03/06/2013CN102952144A Crystal forms of asenapine maleate, and preparation method and medical composition thereof
03/06/2013CN102952138A Salts and polymorphic substances of pyrazolo pyrimidinone compound, pharmaceutical composition thereof, and preparation method and application thereof
03/06/2013CN102952129A Tetrahydropyridodihydropyrimidinone derivative, its preparation method and application
03/06/2013CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof
03/06/2013CN102952112A Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
03/06/2013CN102952107A High-purity beraprost sodium as well as preparation method and application thereof
03/06/2013CN102952105A Mycophenolic acid derivative, preparation method thereof and application thereof
03/06/2013CN102952104A Furan compound
03/06/2013CN102952072A Incarvillateine analogue, as well as preparation and application thereof in analgesics
03/06/2013CN102952069A Compound, and preparation method and application thereof
03/06/2013CN102952062A Substituted benzoheterocyclic compounds and preparation method and application thereof
03/06/2013CN102952059A Amide derivative and preparation method thereof, medicine composition and application
03/06/2013CN102952033A Novel compound, composing method thereof and therapeutic use therefor
03/06/2013CN102949754A Uterine cavity hemostasis anti-adhersion temperature-sensitive gel and preparation method thereof
03/06/2013CN102949726A Medicinal composition
03/06/2013CN102949725A Injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor
03/06/2013CN102949724A Inhalation medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor
03/06/2013CN102949723A Medicinal composition containing glucocorticoid and NOS (Nitric Oxide Synthase) inhibitor for treating skin inflammation
03/06/2013CN102949721A Transdermal absorption pharmaceutical composition containing testosterone and NOS inhibitor
03/06/2013CN102949712A Chinese and western composite medicine for treating neoplastic diseases
03/06/2013CN102949710A Pharmaceutical composition or healthcare product for increasing bone mineral density and preparation method of pharmaceutical composition or healthcare product
03/06/2013CN102949709A External gel used for treating diabetic foot, and preparation method and application thereof
03/06/2013CN102949704A Medicine for treating headache
03/06/2013CN102949696A Medicine for treating cancer and preparation method thereof
03/06/2013CN102949694A Medicinal composition for oral hygiene and disinfection and preparation method of spray of the medicinal composition
03/06/2013CN102949681A Composition for preventing or treating colds, and its preparation method
03/06/2013CN102949648A Traditional Chinese medicine for treating traumatic injury
03/06/2013CN102949647A Medical composition for killing bacteria and relieving itching and preparation method of same
03/06/2013CN102949641A Traditional Chinese preparation for treating beriberi and preparation method for same
03/06/2013CN102949574A Cough-treating tendril-leaved fritillary bulb and loquat sustained release tablet and preparation method thereof
03/06/2013CN102949571A Medicine for treating chronic osteomyelitis
03/06/2013CN102949564A Preparation method of Yinbing acne-elimination tincture
03/06/2013CN102949556A Traditional Chinese medicine preparation for treating arthropathy
03/06/2013CN102949523A Medicinal composition used for relieving visual fatigue and preparation method of capsules thereof
03/06/2013CN102949515A Borneol health-care wine used for controlling conjunctival congestion
03/06/2013CN102949501A External washing lotion for treating gynecological inflammation